BLFS
Price
$34.95
Change
+$0.03 (+0.09%)
Updated
Sep 11 closing price
Capitalization
1.71B
54 days until earnings call
Intraday BUY SELL Signals
STXS
Price
$1.29
Change
-$0.01 (-0.77%)
Updated
Sep 11 closing price
Capitalization
129.26M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLFS vs STXS

BLFS vs STXS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BLFS vs. STXS commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and STXS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.71B) has a higher market cap than STXS($129M). BLFS YTD gains are higher at: 44.541 vs. STXS (-43.913). BLFS has higher annual earnings (EBITDA): 5.18M vs. STXS (-21.17M). BLFS has more cash in the bank: 82.4M vs. STXS (10.5M). STXS has less debt than BLFS: STXS (5.17M) vs BLFS (15.7M). BLFS has higher revenues than STXS: BLFS (107M) vs STXS (30.1M).
BLFSSTXSBLFS / STXS
Capitalization1.71B129M1,326%
EBITDA5.18M-21.17M-24%
Gain YTD44.541-43.913-101%
P/E Ratio34.95N/A-
Revenue107M30.1M355%
Total Cash82.4M10.5M785%
Total Debt15.7M5.17M303%
FUNDAMENTALS RATINGS
BLFS vs STXS: Fundamental Ratings
BLFS
STXS
OUTLOOK RATING
1..100
8419
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
56100
PRICE GROWTH RATING
1..100
3783
P/E GROWTH RATING
1..100
3749
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STXS's Valuation (96) in the Medical Specialties industry is in the same range as BLFS (98). This means that STXS’s stock grew similarly to BLFS’s over the last 12 months.

STXS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BLFS (100). This means that STXS’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's SMR Rating (56) in the Medical Specialties industry is somewhat better than the same rating for STXS (100). This means that BLFS’s stock grew somewhat faster than STXS’s over the last 12 months.

BLFS's Price Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for STXS (83). This means that BLFS’s stock grew somewhat faster than STXS’s over the last 12 months.

BLFS's P/E Growth Rating (37) in the Medical Specialties industry is in the same range as STXS (49). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSSTXS
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 19 days ago
76%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (BLFS: $34.95 vs. STXS: $1.29)
Brand notoriety: BLFS and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLFS: 81% vs. STXS: 51%
Market capitalization -- BLFS: $1.71B vs. STXS: $129.26M
BLFS [@Pharmaceuticals: Other] is valued at $1.71B. STXS’s [@Pharmaceuticals: Other] market capitalization is $129.26M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 0 FA rating(s) are green while STXS’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than STXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 3 TA indicator(s) are bullish while STXS’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 3 bullish, 4 bearish.
  • STXS’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, STXS is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -0.85% price change this week, while STXS (@Pharmaceuticals: Other) price change was -7.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 05, 2026.

STXS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
BLFS
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUNDX29.41N/A
N/A
Mundoval
EVSIX29.93N/A
N/A
Allspring Disciplined US Core Inst
TSFIX16.73N/A
N/A
Touchstone Small Cap Institutional
MWOKX63.87N/A
N/A
MFS Global Growth R6
CSJCX71.74N/A
N/A
Cohen & Steers Realty Shares C